Elite PharmaceuticalsELTP 
$0.38-2.56%24h
-2.56%24h
Global rank13080
Market cap$385.29M
Change 7d5.56%
YTD Performance171.43%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Elite Pharmaceuticals (ELTP)
As of November 2024, Elite Pharmaceuticals has a market cap of $385.29M. This makes Elite Pharmaceuticals the world's 13080th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Elite Pharmaceuticals from 2000 to 2024
-
Value:-
Market cap history of Elite Pharmaceuticals from 2000 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $196.91M | 38.72% |
| 2023 | $141.95M | 366.67% |
| 2022 | $30.42M | 0.00% |
| 2021 | $30.42M | -40.00% |
| 2020 | $50.70M | -44.44% |
| 2019 | $91.25M | 28.57% |
| 2018 | $70.97M | -22.22% |
| 2017 | $91.25M | -40.00% |
| 2016 | $152.09M | -63.41% |
| 2015 | $415.71M | 78.26% |
| 2014 | $233.20M | 91.67% |
| 2013 | $121.67M | 50.00% |
| 2012 | $81.11M | 14.29% |
| 2011 | $70.97M | 75.00% |
| 2010 | $40.56M | -63.64% |
| 2009 | $111.53M | 57.14% |
| 2008 | $70.97M | -96.63% |
| 2007 | $2.11B | -4.59% |
| 2006 | $2.21B | 18.48% |
| 2005 | $1.87B | -49.86% |
| 2004 | $3.72B | 22.33% |
| 2003 | $3.04B | 58.73% |
| 2002 | $1.92B | -70.92% |
| 2001 | $6.59B | 4.00% |
| 2000 | $6.34B | - |
ELTP Market Cap Today is $385.29M -2.56% - 18 Nov 2024
View largest stocks by market cap 
